Back

Specific invalidation of AMP-activated protein kinase alpha1 in cardiac fibroblasts exacerbates left ventricular remodeling following ischemia in mice

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Molecular mechanisms of cardiac disease Fibrosis ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Evangelos-Panagiotis Daskalopoulos

Institute of Experimental and Clinical Research (IREC), Brussels (Belgium)

9 More presentations in this session

Presentation thumbnail
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
Direct monitoring of cAMP at cardiac ryanodine receptor reveals altered beta2-adrenoceptor dependent regulation in hypertrophy
Doctor F. Berisha (Hamburg, DE)
Abstract
Presentation thumbnail
Gene-gene interaction in ischemic cardiopathy by MDR: beyond logistic regression
Professor A. Pereira (Funchal, PT)
Abstract
Presentation thumbnail
Yin-Yang 1 transcription factor modulates sST2 on adverse cardiac remodeling post-myocardial infarction
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
Sphingosine-1-phosphate receptor 2 agonist mobilizes endogenous muse cells from bone marrow via S1P-S1PR2 axis for cardiac tissue repair after acute myocardial infarction
Doctor S. Minatoguchi (Gifu, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Molecular mechanisms of cardiac disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Quantitative molecular imaging of cardiac fibrosis and response to treatment using a novel collagen III-specific MR imaging probe
thumbnail
Congress Presentation
Heart failure in the era of single-nuclei and spatial OMICs
thumbnail
Congress Presentation
How do we assess fibrosis in athletic individuals? current practice and novel advances

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources